TRICCAR, Inc. Share Price Other OTC
Equities
TCCR
US89609L1017
Biotechnology & Medical Research
Sales 2022 | 3.4 271.17 | Sales 2023 | 7.56 602.54 | Capitalization | 50.68M 4.04B |
---|---|---|---|---|---|
Net income 2022 | -7M -558M | Net income 2023 | -12M -956M | EV / Sales 2022 | 11,527,301 x |
Net Debt 2022 | 1.79M 143M | Net Debt 2023 | 2.2M 176M | EV / Sales 2023 | 6,992,018 x |
P/E ratio 2022 |
-5.17
x | P/E ratio 2023 |
-3.94
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.85% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Michaels
CEO | Chief Executive Officer | 49 | 27/12/21 |
Johan Themaat
DFI | Director of Finance/CFO | - | 31/08/23 |
Matthew Flemming
CHM | Chairman | 56 | 13/05/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Flemming
CHM | Chairman | 56 | 13/05/21 |
G. Powell
BRD | Director/Board Member | 60 | 27/12/21 |
Jason Loyet
BRD | Director/Board Member | 49 | 27/12/21 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |